Forest Investigative Site 1443 — Philadelphia, Pennsylvania

Forest Investigative Site 1443 is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1443 has participated in 3 clinical trials.

Therapeutic areas: Chronic Obstructive Pulmonary Disease.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1443?

Forest Investigative Site 1443 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1443 conducted?

Forest Investigative Site 1443 has 3 clinical trials on record. Their work covers Chronic Obstructive Pulmonary Disease.

Is Forest Investigative Site 1443 accredited by Crixeo Health?

Forest Investigative Site 1443 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1443?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.